advertisement
Wang K 42
Showing records 1 to 25 | Display all abstracts from Wang K128683 Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy
Pu N
Antioxidants (Basel, Switzerland) 2025; 14:
127260 Analysis of the correlation between mental status and ocular and systemic indicators in patients with primary angle-closure glaucoma
Cheng S
BMC Ophthalmology 2025; 25: 393
128683 Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy
Pu N
Antioxidants (Basel, Switzerland) 2025; 14:
128535 Piezoresistive MOF for Intraocular Pressure Monitoring
Zha X
ACS sensors 2025; 10: 6656-6664
128800 Unveiling the link: aging and its impact on ocular diseases
Wang K
Experimental Eye Research 2025; 259: 110551
127260 Analysis of the correlation between mental status and ocular and systemic indicators in patients with primary angle-closure glaucoma
Cheng S
BMC Ophthalmology 2025; 25: 393
128535 Piezoresistive MOF for Intraocular Pressure Monitoring
Zhou N
ACS sensors 2025; 10: 6656-6664
128800 Unveiling the link: aging and its impact on ocular diseases
Xie Y
Experimental Eye Research 2025; 259: 110551
127260 Analysis of the correlation between mental status and ocular and systemic indicators in patients with primary angle-closure glaucoma
Deng P
BMC Ophthalmology 2025; 25: 393
128683 Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy
Li S
Antioxidants (Basel, Switzerland) 2025; 14:
127260 Analysis of the correlation between mental status and ocular and systemic indicators in patients with primary angle-closure glaucoma
Du L
BMC Ophthalmology 2025; 25: 393
128683 Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy
Wu H
Antioxidants (Basel, Switzerland) 2025; 14:
128535 Piezoresistive MOF for Intraocular Pressure Monitoring
Hu M
ACS sensors 2025; 10: 6656-6664
128800 Unveiling the link: aging and its impact on ocular diseases
Lin Y
Experimental Eye Research 2025; 259: 110551
127260 Analysis of the correlation between mental status and ocular and systemic indicators in patients with primary angle-closure glaucoma
Wang K
BMC Ophthalmology 2025; 25: 393
128683 Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy
Zhao N
Antioxidants (Basel, Switzerland) 2025; 14:
128535 Piezoresistive MOF for Intraocular Pressure Monitoring
Chen K
ACS sensors 2025; 10: 6656-6664
128800 Unveiling the link: aging and its impact on ocular diseases
Zhu R
Experimental Eye Research 2025; 259: 110551
128535 Piezoresistive MOF for Intraocular Pressure Monitoring
Iita NS
ACS sensors 2025; 10: 6656-6664
128800 Unveiling the link: aging and its impact on ocular diseases
Gao T
Experimental Eye Research 2025; 259: 110551
127260 Analysis of the correlation between mental status and ocular and systemic indicators in patients with primary angle-closure glaucoma
He X
BMC Ophthalmology 2025; 25: 393
128683 Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy
Wang K
Antioxidants (Basel, Switzerland) 2025; 14:
128800 Unveiling the link: aging and its impact on ocular diseases
Han Z
Experimental Eye Research 2025; 259: 110551
127260 Analysis of the correlation between mental status and ocular and systemic indicators in patients with primary angle-closure glaucoma
Xiang Y
BMC Ophthalmology 2025; 25: 393
128683 Beacon of Hope for Age-Related Retinopathy: Antioxidative Mechanisms and Pre-Clinical Trials of Quercetin Therapy
Wei D
Antioxidants (Basel, Switzerland) 2025; 14:
